In our first reports on calcitonin DT and thyroglobulin DT, 17% of patients with MTC (Fig. 1) and 16% of patients with PTC (Table 1), respectively, had tumor marker DT of negative values [5, 9]. This evidence concerns the gene CALCA and neoplasm.